NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Specified Drug-use Survey of Leqvio for s.c. Injection.

Active Not RecruitingN/A

Sponsor: Novartis Pharmaceuticals

Conditions: Familial Hypercholesterolaemia, Hypercholesterolaemia

Interventions: inclisiran

Countries: Japan

The objective of this study is to evaluate the long-term safety of Leqvio in patients with familial hypercholesterolaemia or hypercholesterolaemia in post-marketing clinical practice

Eligibility overview

Sex: ALL

Age: 15 Years to 100 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients who provided written informed consent to participate in this survey prior to the start of treatment with Leqvio.
* Patients who received treatment with Leqvio as per the package insert.

Exclusion Criteria:

* Patients who received treatment with a formulation containing the same ingredients as Leqvio in the past.
* Patients participating in other interventional studies at the time of informed consent.
* Patients planning to participate in other interventional studies during this survey.

Locations (107)

Handa, Aichi-ken, Japan
Ichinomiya, Aichi-ken, Japan
Ichinomiya, Aichi-ken, Japan
Komaki, Aichi-ken, Japan
Nagoya, Aichi-ken, Japan
Nagoya, Aichi-ken, Japan
Toyoake, Aichi-ken, Japan
Tsushima, Aichi-ken, Japan
Asahi, Chiba, Japan
Inzai, Chiba, Japan
Urayasu, Chiba, Japan
Matsuyama, Ehime, Japan
Fukui-shi, Fukui, Japan
Fukuoka, Fukuoka, Japan
Fukuoka, Fukuoka, Japan
Kitakyushu, Fukuoka, Japan
Kitakyushu, Fukuoka, Japan
Fukushima, Fukushima, Japan
Kōriyama, Fukushima, Japan
Shirakawa, Fukushima, Japan
Gifu, Gifu, Japan
Hiroshima, Hiroshima, Japan
Kure, Hiroshima, Japan
Asahikawa, Hokkaido, Japan
Asahikawa, Hokkaido, Japan
Sapporo, Hokkaido, Japan
Sapporo, Hokkaido, Japan
Sapporo, Hokkaido, Japan
Amagasaki, Hyōgo, Japan
Himeji, Hyōgo, Japan
+ 77 more on CT.gov